Perpetuum CropScience
ActiveSummary
The computed 12-month bankruptcy probability of Perpetuum CropScience is 12.0% (high). The 2025 annual accounts show negative equity (-€65,256) and a net result of -€31,491. Equity has been shrinking by about 67% per year since 2019. Its solvency ranks better than 9% of 617 sector peers (NACE 72, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry.
Overview
Overview
Official details
Source: KBO- Status
- Active since 12-03-2019 Normal situation
- Activity
- Research and development on biotechnology NACE 72101and 1 other
- Establishment unit
- 2.288.464.184 9120 Beveren-Kruibeke-Zwijndrecht, since 12-03-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 15-04-2026
Board and ownership
- Troch JamesDirector · since 12-03-2019
- Jeroen Hofenk50.92%annual accounts 2021
- James Troch49.08%annual accounts 2021
- Holdings
- Shares in 1 company Perpetuum Cropscience Canada Inc
Financial position
- Bankruptcy probabilitywithin 12 months
- 12.0%
- Gross margin
- -€13,933
- ▼ 38.5%
- Loss
- €31,491
- ▲ 72.4%
- Equity
- -€65,256
- ▼ 93.3%
- Total assets
- €181,346
- ▼ 1.3%
- Negative equity on 31-12-2025
- 2025 accounts filed 62 days after the deadline
Score breakdownraises riskLast filed accounts filed 62 days late; 3 of the last 3 accounts lateEx-officio strike-off in the KBOLiquidity: current ratio 1.04, cash €1051 change of registered office in 24 monthsShow the evidence
Checked score
About 1 in 8 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 6% of them on solvency, 6% on liquidity, 10% on profitability and 8% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 162 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (1)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 01-10-2026 at the NBB all 7 filings
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result for 2025 is a loss of €28,754, larger than the loss of €21,912 in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Scientific research and development (NACE 72). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Staff
| Item | 31-12-2021 |
|---|---|
| Average over the year, in full-time equivalents | 0.2 |
| Joined | 1 |
| Left | 1 |
Source: social balance sheet in the 2021 annual accounts
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Intangible fixed assets | €42,324 | - | €12,236 | €20,296 | €14,712 |
| Financial fixed assets | - | - | - | - | €0 |
| Depreciation and write-downs of the year | €16,756 | €16,062 | €10,237 | €10,832 | €14,251 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Comparable companies
These companies have the same main activity as Perpetuum CropScience: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €135,000 and €234,000, founded between 2017 and 2021.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| Perpetuum CropScience Beveren-Kruibeke-Zwijndrecht | 2019 | €0.2m | -€0.07m | -€0.01m | -€0.03m | - | 2025 |
| Clino Consult Beveren-Kruibeke-Zwijndrecht | 2019 | €0.2m | €0.2m | -€0.002m | -€0.02m | - | 2025 |
| VERBO CLINICAL QUALITY ASSURANCE Ieper | 2020 | €0.2m | €0.1m | -€0.007m | -€0.002m | - | 2025 |
| ProteoFormiX Vorselaar | 2017 | €0.2m | -€0.2m | -€0.005m | -€0.04m | - | 2025 |
| Arquebus Solutions Europe Machelen (Brab.) | 2020 | €0.2m | -€0.06m | -€0.008m | -€0.02m | - | 2025 |
| IDRO Antwerpen | 2020 | €0.2m | -€0.3m | €0.002m | -€0.2m | 2.5 | 2025 |
| GRAND MEDICAL (EUROPE) Niel | 2021 | €0.1m | -€1.4m | -€0.08m | -€0.2m | 0.4 | 2025 |
They were chosen from the 498 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 6,007 companies had the same profile as Perpetuum CropScience has now. Two years later, 7.9% had gone bankrupt and 83.0% were still going.
- Micro
- 5 to 10 years old
- negative equity
- a loss of 10% of the balance sheet or more
Another 0.8% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Perpetuum CropScience itself is higher: 12.0% within 12 months. It rests on far more data about Perpetuum CropScience than the profile alone.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,007 companies, not a prediction for Perpetuum CropScience. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | €8,338 | - | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €5,822 | €12,980 | €16,756 | €16,062 | €10,237 | €10,832 | €14,251 | ▲ 31.6% |
| Other operating charges640/8 | - | - | €101 | €102 | €109 | €1,018 | €570 | ▼ 44.0% |
| Gross operating margin9900 | €26,932 | €49,540 | -€13,983 | -€22,030 | -€20,698 | -€10,062 | -€13,933 | ▼ 38.5% |
| Operating profit (loss)9901 | €21,110 | €36,238 | -€39,179 | -€38,194 | -€31,044 | -€21,912 | -€28,754 | ▼ 31.2% |
| Financial income75/76B | - | - | €1,748 | €4,186 | €3,897 | €5,581 | €192 | ▼ 96.6% |
| Recurring financial income75 | €24 | €1,098 | €1,748 | €4,186 | €3,897 | €5,581 | €192 | ▼ 96.6% |
| Financial charges65/66B | - | - | €570 | €1,573 | €1,696 | €1,937 | €2,929 | ▲ 51.2% |
| Recurring financial charges65 | €253 | €403 | €570 | €1,573 | €1,696 | €1,937 | €2,929 | ▲ 51.2% |
| Profit (loss) for the period before taxes9903 | €20,881 | €36,934 | -€38,001 | -€35,581 | -€28,843 | -€18,268 | -€31,491 | ▼ 72.4% |
| Income taxes67/77 | €3,547 | €6,227 | - | - | - | - | - | - |
| Profit (loss) for the period9904 | €17,334 | €30,706 | -€38,001 | -€35,581 | -€28,843 | -€18,268 | -€31,491 | ▼ 72.4% |
| Profit (loss) for the period to be appropriated9905 | €17,334 | €30,706 | -€38,001 | -€35,581 | -€28,843 | -€18,268 | -€31,491 | ▼ 72.4% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €35,643 | €143,680 | €183,060 | €161,000 | €153,720 | €183,767 | €181,346 | ▼ 1.3% |
| Fixed assets21/28 | €11,652 | €30,049 | €55,617 | €28,879 | €30,878 | €40,342 | €40,803 | ▲ 1.1% |
| Intangible fixed assets21 | €11,645 | €30,042 | €55,610 | €28,872 | €30,871 | €40,335 | €40,796 | ▲ 1.1% |
| Financial fixed assets28 | €7 | €7 | €7 | €7 | €7 | €7 | €7 | ▼ 5.1% |
| Current assets29/58 | €23,992 | €113,631 | €127,443 | €132,121 | €122,842 | €143,425 | €140,543 | ▼ 2.0% |
| Amounts receivable after more than one year29 | - | - | €63,478 | €65,670 | €67,972 | €64,333 | €65,491 | ▲ 1.8% |
| Trade receivables290 | - | - | - | €65,670 | €67,972 | €64,333 | €0 | ▼ 100% |
| Other amounts receivable291 | - | - | €63,478 | - | - | - | €65,491 | - |
| Stocks and contracts in progress3 | - | €21,683 | €26,487 | €12,414 | - | - | - | - |
| Stocks30/36 | - | - | €26,487 | €12,414 | - | - | - | - |
| Amounts receivable within one year40/41 | €2,859 | €33,088 | €37,153 | €51,554 | €54,617 | €79,043 | €74,947 | ▼ 5.2% |
| Trade receivables40 | - | - | €650 | €21,948 | €21,948 | €21,948 | €21,162 | ▼ 3.6% |
| Other amounts receivable41 | - | - | €36,503 | €29,606 | €32,669 | €57,095 | €53,785 | ▼ 5.8% |
| Cash at bank and in hand54/58 | €332 | €43 | €326 | €2,483 | €253 | €49 | €105 | ▲ 113% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €35,643 | €143,680 | €183,060 | €161,000 | €153,720 | €183,767 | €181,346 | ▼ 1.3% |
| Equity10/15 | €26,222 | €56,928 | €33,927 | -€1,654 | -€30,497 | -€33,765 | -€65,256 | ▼ 93.3% |
| Contributions10/11 | €8,888 | - | €23,888 | €23,888 | €23,888 | €38,888 | €38,888 | = |
| Reserves13 | €17,334 | €48,040 | €10,039 | - | - | - | - | - |
| Distributable reserves133 | - | - | €10,039 | - | - | - | - | - |
| Profit (loss) carried forward14 | - | - | - | -€25,542 | -€54,385 | -€72,653 | -€104,144 | ▼ 43.3% |
| Amounts payable17/49 | €9,422 | €86,752 | €149,133 | €162,654 | €184,217 | €217,532 | €246,602 | ▲ 13.4% |
| Amounts payable after more than one year17 | €4,000 | €13,645 | €12,727 | €44,239 | €66,119 | €77,345 | €111,714 | ▲ 44.4% |
| Financial debts170/4 | - | - | €12,727 | €44,239 | €66,119 | €77,345 | €111,714 | ▲ 44.4% |
| Amounts payable within one year42/48 | €5,422 | €73,107 | €136,406 | €118,415 | €118,098 | €140,187 | €134,821 | ▼ 3.8% |
| Trade debts44 | - | €58,484 | €125,235 | €117,065 | €118,098 | €132,805 | €123,593 | ▼ 6.9% |
| Suppliers440/4 | - | - | €125,235 | €117,065 | €118,098 | €132,805 | €123,593 | ▼ 6.9% |
| Taxes, remuneration and social security45 | - | - | €6,227 | €1,350 | - | - | - | - |
| Taxes450/3 | - | - | €6,227 | €1,350 | - | - | - | - |
| Other amounts payable47/48 | - | - | €4,943 | - | - | €7,382 | €11,228 | ▲ 52.1% |
| Accrued charges and deferred income492/3 | - | - | - | - | - | - | €67 | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €17,334 | €30,706 | -€38,001 | -€35,581 | -€28,843 | -€18,268 | -€31,491 | ▼ 72.4% |
| + Depreciation and write-downs630 | €5,822 | €12,980 | €16,756 | €16,062 | €10,237 | €10,832 | €14,251 | ▲ 31.6% |
| Operating cash flow (approximation) | €23,156 | €43,686 | -€21,244 | -€19,519 | -€18,606 | -€7,436 | -€17,240 | ▼ 132% |
| Investment in fixed assets (approximation) | - | -€31,377 | -€42,324 | €10,676 | -€12,236 | -€20,296 | -€14,712 | ▲ 27.5% |
| Change in cash | - | -€289 | €283 | €2,157 | -€2,230 | -€204 | €56 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Filings with the National Bank (7)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 01-10-2026 | 2026-00539878 | NBB |
| 31-12-2024 | micro format | 30-09-2025 | 2025-00524542 | |
| 31-12-2023 | micro format | 27-05-2025 | 2025-00108778 | |
| 31-12-2022 | micro format | 27-05-2025 | 2025-00108779 | |
| 31-12-2021 | abbreviated format | 24-06-2022 | 2022-20125277 | |
| 31-12-2020 | abbreviated format | 27-10-2021 | 2021-73900151 | |
| 31-12-2019 | micro format | 27-07-2020 | 2020-34300563 |
Board & ownership
Directors
Owners and capital
Shareholders
2 ownersOwners 2
- Jeroen Hofenknatural personSourceown accounts 202150.92%
- James Trochnatural personSourceown accounts 202149.08%
Network & group
Holdings and subsidiaries
1 holdingHoldings 1
- Perpetuum Cropscience Canada IncCAsubsidiarySourceown accounts 2021100%
Connections & network
1 current directorThe network starts from the directors of Perpetuum CropScience. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
03-03
Gazette deed
Registered office moved from Antwerpen to Beveren-Kruibeke-Zwijndrecht2 points ▸
- Board meeting, 12-11-2025
- Registered-office move, Schaarbeekstraat 20D / 1, 9120 Beveren-Kruibeke-Zwijndrecht
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 46016D1409/00A000 | Flanders | 3,924 m² | 1 · 1,448 m² | 11.5 m |